On January 23, Jinshi Data News, Aupmai announced that the company is planning to purchase the controlling rights of Pengli Biology through the issuance of shares and payment of cash, while raising matching funds. There is still significant uncertainty in this transaction, and the company's stock will continue to be suspended from trading from the morning of Friday, January 24, 2025, with an expected suspension period of no more than 5 trading days.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Aopumai: Intends to acquire control of Pengli Biology, and the stock will continue to be suspended for no more than 5 trading days.
On January 23, Jinshi Data News, Aupmai announced that the company is planning to purchase the controlling rights of Pengli Biology through the issuance of shares and payment of cash, while raising matching funds. There is still significant uncertainty in this transaction, and the company's stock will continue to be suspended from trading from the morning of Friday, January 24, 2025, with an expected suspension period of no more than 5 trading days.